Enanta Pharmaceuticals Inc SEC filings ENTA
Enanta Pharmaceuticals Inc has 835 filings in SEC EDGAR's recent list, going back to Jun 21, 2002. Its latest annual report, Form ARS, was filed on Jan 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jan 26, 2026 | — |
| DEF 14A | Proxy statement | Jan 26, 2026 | Mar 11, 2026 |
| DEFA14A | Additional proxy material | Jan 27, 2025 | — |
| DEF 14A | Proxy statement | Jan 27, 2025 | Mar 13, 2025 |
| DEFA14A | Additional proxy material | Jan 26, 2024 | — |
| DEF 14A | Proxy statement | Jan 26, 2024 | Mar 6, 2024 |
| DEFA14A | Additional proxy material | Jan 20, 2023 | — |
| DEF 14A | Proxy statement | Jan 20, 2023 | Mar 2, 2023 |
| DEFA14A | Additional proxy material | Jan 21, 2022 | — |
| DEF 14A | Proxy statement | Jan 21, 2022 | Mar 3, 2022 |
| DEF 14A | Proxy statement | Jan 21, 2021 | Mar 2, 2021 |
| DEFA14A | Additional proxy material | Jan 21, 2021 | — |
| DEFA14A | Additional proxy material | Jan 17, 2020 | — |
| DEF 14A | Proxy statement | Jan 17, 2020 | Feb 26, 2020 |
| DEFA14A | Additional proxy material | Jan 18, 2019 | — |
| DEF 14A | Proxy statement | Jan 18, 2019 | Feb 28, 2019 |
| DEFA14A | Additional proxy material | Jan 19, 2018 | — |
| DEF 14A | Proxy statement | Jan 19, 2018 | Feb 28, 2018 |
| DEFA14A | Additional proxy material | Jan 6, 2017 | — |
| DEF 14A | Proxy statement | Jan 6, 2017 | Feb 16, 2017 |
| DEF 14A | Proxy statement | Jan 13, 2016 | Feb 11, 2016 |
| DEF 14A | Proxy statement | Jan 15, 2015 | Feb 19, 2015 |
| DEF 14A | Proxy statement | Jan 10, 2014 | Feb 6, 2014 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ENTA (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1177648
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.